New York Life Investment Management’s argenx ARGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
1,102
+32
+3% +$26.4K 0.01% 687
2026
Q1
$781K Buy
1,070
+93
+10% +$72.8K 0.01% 711
2025
Q4
$822K Sell
977
-98
-9% -$83.9K 0.01% 648
2025
Q3
$793K Buy
1,075
+35
+3% +$23.1K 0.01% 703
2025
Q2
$573K Sell
1,040
-44
-4% -$25.5K 0.01% 749
2025
Q1
$642K Sell
1,084
-77
-7% -$48.6K 0.01% 737
2024
Q4
$714K Buy
1,161
+294
+34% +$172K 0.01% 731
2024
Q3
$470K Sell
867
-35
-4% -$17.7K ﹤0.01% 815
2024
Q2
$388K Buy
902
+8
+0.9% +$3.06K ﹤0.01% 814
2024
Q1
$352K Sell
894
-84
-9% -$32.5K ﹤0.01% 1283
2023
Q4
$372K Buy
978
+48
+5% +$22.4K ﹤0.01% 1057
2023
Q3
$457K Buy
930
+3
+0.3% +$1.47K ﹤0.01% 799
2023
Q2
$361K Buy
927
+26
+3% +$10.2K ﹤0.01% 1137
2023
Q1
$336K Sell
901
-17
-2% -$6.29K ﹤0.01% 1159
2022
Q4
$348K Sell
918
-52
-5% -$19.5K ﹤0.01% 1094
2022
Q3
$342K Buy
970
+44
+5% +$16.3K ﹤0.01% 1043
2022
Q2
$351K Buy
+926
New +$298K ﹤0.01% 1083

Other funds holding ARGX

New York Life Investment Management's ARGX Position: Q2 2026 in Review

New York Life Investment Management increased its argenx (ARGX) stake by 3% in Q2 2026, buying an estimated $26.4K and bringing the position to 1,102 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #687.

New York Life Investment Management first reported a position in ARGX in Q2 2022 and has held it in 17 quarters since. 276 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • New York Life Investment Management held 1,102 shares of argenx worth $1.02M as of Q2 2026.
  • New York Life Investment Management bought 32 argenx shares in Q2 2026, an estimated $26.4K.
  • argenx made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #687 holding.
  • New York Life Investment Management first reported a position in argenx in Q2 2022 and has held it in 17 quarters since.
  • 276 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.